Rheumatoid Arthritis Work Limitation Factors
Rheumatic and musculoskeletal diseases (RMD) introduce pain and functional limitations into the workplace, affecting individuals with rheumatoid arthritis and osteoarthritis. This study delves into the multifaceted factors that shape the work challenges arising from RMD, acknowledging the broader societal costs involved. By shedding light on these complexities, the research seeks to empower individuals grappling with RMD, offering valuable insights for health professionals and fostering a more supportive work environment.
THE BACKGROUND OF THE STUDY
Rheumatic and musculoskeletal diseases (RMD) present a multifaceted challenge, causing pain, fatigue, and functional limitations with implications for work participation . Conditions like rheumatoid arthritis (RA), axial spondyloarthritis (axSpA), osteoarthritis (OA), and fibromyalgia (FM) contribute to the global burden of work disability, posing financial costs at societal, organizational, and individual levels . Global estimates of RMD prevalence underscore their significance, ranging from 0.46% in RA to 6.6% in FM .
Onset during working age emphasizes the potential for extended work with these conditions . Understanding and managing RMD-related difficulties in the workforce is crucial due to its repercussions on the economy, especially in the United Kingdom, where expenses for osteoarthritis and rheumatoid arthritis alone are projected to reach £3.43 billion by 2030 . Furthermore, this study is pertinent as countries raise pension ages, given that a third of UK workers are over 50, and individuals with RMD face increased risks of presenteeism, absenteeism, and work disability .
The UK Government’s ‘Improving Lives’ strategy aims to facilitate the inclusion of disabled individuals in the workforce, aligning with the imperative to enable people with disabilities or ill-health to remain employed . Factors influencing presenteeism, absenteeism, and work disability in RMD encompass symptoms, functional limitations, psychological aspects, workplace conditions, and societal factors . This study explores work limitations experienced by individuals with rheumatoid arthritis, axial spondyloarthritis, osteoarthritis, or fibromyalgia and explores associated factors aiding health and occupational professionals in crafting effective interventions .
THE STUDY METHOD
The study adopted a cross-sectional design, conducting a secondary analysis of a survey evaluating the psychometric properties of work patient-reported outcome measures in rheumatoid arthritis (RA), axial spondyloarthritis (axSpA), osteoarthritis (OA), and fibromyalgia (FM). Participants were recruited from diverse healthcare settings in the UK, including secondary care and community National Health Service (NHS) Trusts, along with a University Arthritis Volunteer Register.
Eligible participants, aged at least 18, engaged in paid work for at least one (1) day a week (including self-employed), currently at work, and diagnosed with RA, axSpA, knee and hip OA, or FM, formed the study cohort. Exclusion criteria encompassed long-term sick leave and language limitations, with provision for those on short-term ill leave to participate upon return to work.
A comprehensive literature search and overview review were conducted to identify factors associated with presenteeism, absenteeism, and work participation in the four rheumatic and musculoskeletal diseases. A total of 78 factors were identified, with 33 linked to variables available in the dataset.
Data collection spanned from March 2018 to March 2020. The Workplace Activity Limitations Scale (WALS) gauged work limitations, encompassing personal, health, and work characteristics. Condition-specific measures were included for RA, axSpA, OA, and FM. Additionally, assessments covered individual contextual factors, work-related environmental contextual factors, and the need for work adjustments and policies.
Responses within the dataset determined the sample size.
The study’s variables were summarized using descriptive statistics such as mean (standard deviation), median (interquartile range), and number (percentage). The one-way ANOVA, Kruskal-Wallis, and Chi-square tests were used to compare conditions. Statistical significance was set at p ≤ 0.05.
Multivariable regression, controlling for age and sex if relevant, examined independent variables associated with the Workplace Activity Limitations Scale (WALS) for each condition separately. Bivariate regression analyses identified variables for inclusion based on significance (p ≤ 0.05) and correlation (r ≥ 0.3). Pearson’s correlations assessed multicollinearity, and items were omitted if correlations were ≥0.8. Collinearity diagnostic tests were examined, and variables not meeting requirements were omitted.
Two multivariable regression analyses were conducted for each condition. Variables entered met selection criteria based on condition-specific literature and a cross-condition literature review. The forced entry method was used, sequentially dropping variables based on descending p values. Retained variables had a p-value ≤0.05. Analysis used SPSS v26 (IBM, 201).
The study provides an overview of key findings in the results section, highlighting differences and associations among participants with different rheumatic conditions.
– 879 out of 1359 patients (64.7%) returned the study questionnaire.
– 822 participants (60.5% overall) were included, with 4.2% ineligible.
Personal Factors, Health, and Job Characteristics:
– Varied demographic characteristics among different rheumatic conditions.
– Participants with OA or RA were significantly older than those with axSpA or FM.
– Significant differences in living arrangements and children at home.
– Educational levels were similar across groups.
– AxSpA participants had longer diagnosis duration and more full-time employment.
– Participants with FM had higher Work Activity Limitation Scores (WALS) and more difficulties than RA, OA, and axSpA.
– High WALS scores indicated moderate to high work instability.
– Specific work limitations varied among conditions, e.g., concentration in FM hand-related issues in RA.
– FM participants received more help and adaptations.
Functioning and Disability Factors:
– FM participants are generally worse on generic measures; axSpA is often better than RA and OA.
– Differences in body parts affected; FM and OA reported more severe difficulties.
– AxSpA had higher work self-efficacy, work-health-personal life balance, and motivation to continue working.
Work-Related Contextual Factors:
– AxSpA participants worked longer hours, more often in small enterprises, and had greater work self-efficacy.
– Varied levels of job control, with FM reporting less managerial and organizational support.
– FM required more work accommodations than other conditions.
Factors Associated with Work Limitations:
– Various factors associated with work limitations, including personal, functioning, work-related personal, and environmental factors.
– Multivariable regression analyses showed different factors across conditions.
– Across conditions, functional limitations, job strain, pain, and work-life balance were associated with work limitations.
This study explored workplace activity limitations among individuals with rheumatoid arthritis (RA), axial spondyloarthritis (axSpA), osteoarthritis (OA), and fibromyalgia (FM) using the Workplace Activity Limitations Scale (WALS), recognized as one of the optimal presenteeism measures for Rheumatic Musculoskeletal Diseases (RMD) by the Outcome Measures in Rheumatology Worker Productivity Group . Work limitations were compared across conditions, revealing that FM participants experienced the highest limits. Unlike previous studies comparing RA and OA or RA and axSpA, this study encompassed all three illnesses. It also included FM, identifying gaps in knowledge about presenteeism and contextual factors in FM .
Notably, participants with FM reported worse function, pain, fatigue, job strain, work self‐efficacy, and work‐life balance than those with rheumatoid arthritis and OA, whereas RA exhibited better function scores. FM participants perceived less control over work, lower support, and required more accommodations. Fibromyalgia diagnosis delays may contribute to difficulties explaining work issues to employers, potentially resulting in more significant work challenges .
Workplace Activity Limitations Scale scores indicated moderate to high work instability for two-thirds or more of participants with OA, FM, and RA and just under half of those with axSpA. It suggested better disease control in axSpA, possibly associated with biologics use. However, in RA, participants exhibited moderate to high work instability scores alongside relatively low Health Assessment Questionnaire (HAQ) function scores .
Participants reported difficulties with a substantial portion of work activities yet only received help or adaptations for a quarter or less, highlighting the need for workplace adaptations, especially for those with moderate and high work instability . Factors associated with greater presenteeism were identified across conditions, with a functional decline seen in all the illnesses. Other condition-specific factors included tremendous job strain, the need for work accommodations, poorer work-life balance, more significant pain, greater mental–interpersonal job demands, lower perceived work support, worse perceived health, and poorer work self‐efficacy .
Disclosing the condition to employers did not eliminate the need for work accommodations, and participants reported challenges, including a need for more understanding and support from employers . Overlapping factors associated with greater presenteeism highlighted the importance of considering modifiable factors in non-pharmacological interventions, emphasizing the need for active employer engagement .
This study’s findings align with research in general working populations, emphasizing the similarity of factors affecting presenteeism in RMDs to those influencing the general working population. The study advocates for condition-specific vocational rehabilitation alongside broader workplace practices, such as flexible working arrangements, home or hybrid working, and effective line management practices to mitigate presenteeism .
LIMITATIONS OF THE STUDY
- Cross-Sectional Design: The study’s cross‐sectional nature limits establishing causality, as it does not allow for examining causal relationships. Longitudinal studies would be necessary to explore causation over time.
- Sampling Bias: Participants were recruited from community and hospital outpatient clinics, introducing a potential selection bias. This sample may not fully represent the entire population with these conditions. The absence of consecutive sampling further limits the generalizability of findings, as recruitment depends on the availability of research nurses/facilitators and therapy staff.
- Self-Selection Bias: While the study emphasized eligibility for those with no or few work problems, the voluntary nature of participation raises the possibility of self-selection bias. Individuals experiencing minimal work problems may have been more inclined to participate, potentially skewing the study’s perspective.
- Gender Disparity in FM Participants: The study faced challenges in recruiting a sufficient number of men with Fibromyalgia (FM), leading to underrepresentation. This gender disparity might limit the generalizability of findings, particularly for male individuals with FM.
- Study Focus and Design: The WORK‐PROM study primarily aimed to evaluate the psychometrics of measures rather than comprehensively evaluating factors influencing presenteeism. This limited scope may have overlooked various important variables influencing work-related outcomes.
- Literature Review Gaps: The literature review acknowledged that several potentially significant variables were not included in the study. The omission of factors such as compensation for absence, income needs, and family support, identified by the Outcome Measures in Rheumatology Worker Productivity Group (Boonen et al., 2021), indicates a gap that may affect the completeness of the study’s findings.
In summary, while the study provides valuable insights, its cross‐sectional design, sampling approach, potential self-selection bias, gender disparity in FM participants, study focus, and literature review gaps introduce limitations that should be considered when interpreting the results. Future research with a more diverse and representative sample, longitudinal design, and comprehensive consideration of relevant variables could address some limitations.
In conclusion, this study enhances understanding of work limitations in individuals with rheumatoid arthritis, axSpA, OA, and FM, revealing significant work instability and a need for increased accommodation support. While the findings may be more applicable to those treated in therapy and outpatient clinics, the high prevalence of work limitations in FM suggests a broader need for work support. The study identifies personal and contextual factors associated with presenteeism, emphasizing the importance of early identification and tailored work interventions to prevent future disability. Health professionals play a crucial role in initiating such support, contributing to the overall goal of maintaining individuals with rheumatic and musculoskeletal diseases in the workforce.
- Gignac, M. A. M., Cao, X., & Tang, K. (2011). Psychosocial work factors and processes influencing older workers’ health: A 3-year longitudinal analysis. Journal of Aging and Health, 23(3), 547-578. https://acrjournals.onlinelibrary.wiley.com/doi/epdf/10.1002/acr.20456
- Bevan, S., Quadrello, T., McGee, R., Mahdon, M., Vavrovsky, A., & Barham, L. (2013). Fit for work? Musculoskeletal disorders in the European workforce. The Work Foundation. https://www.bl.uk/collection-items/reducing-temporary-work-absence-through-early-intervention-the-case-of-msds-in-the-eu
- Almutairi, K., Nossent, J., & Preen, D. (2021). The worldwide prevalence of rheumatoid arthritis: A systematic review and meta-analysis. Clinical Rheumatology, 40(2), 271-281. https://pubmed.ncbi.nlm.nih.gov/33175207/
- Stolwijk, C., van Onna, M., Boonen, A., van Tubergen, A., & Global SpA Research Alliance (2016). Global prevalence of spondyloarthritis: A systematic review and meta-regression analysis. Arthritis Care & Research, 68(9), 1320-1331. https://pubmed.ncbi.nlm.nih.gov/26713432/
- Cui, A., Li, H., Wang, D., Zhong, J., Chen, Y., & Lu, H. (2020). Global, regional prevalence, incidence and risk factors of knee osteoarthritis in population-based studies. EClinicalMedicine, 29-30, 100587. https://doi.org/10.1016/j.eclinm.2020.100587
- Heidari, B., Hajian-Tilaki, K., & Heidari, P. (2017). Musculoskeletal pain and its associated factors in Iranian population: A nationwide multicenter study. Clinical Rheumatology, 36(11), 2577-2589. https://pubmed.ncbi.nlm.nih.gov/21199469/
- Department of Work and Pensions (DWP) & Department of Health (DH). (2017). Improving Lives: The Future of Work, Health and Disability. UK Government.https://www.gov.uk/government/publications/improving-lives-the-future-of-work-health-and-disability
- Gilworth, G., et al. (2003). Rheumatic and musculoskeletal diseases in the workforce: A review of literature and identification of knowledge gaps. Arthritis Care & Research, 49(5), 625-631. https://onlinelibrary.wiley.com/doi/epdf/10.1002/art.1111
- Brown ET, et al. (2023). Workplace activity limitations in rheumatic and musculoskeletal diseases: A multicenter cross-sectional study. *Musculoskeletal Care,* 21(3), 828-841. https://doi.org/10.1002/msc.1760
Oncology Related Tools
- Prognostic Scoring for Myelofibrosis
- Opioid Conversion Calculator
- Updated Advanced Opioid Conversion Calculator
- Nonsteroidal anti-inflammatory drugs (NSAID) Selection Tool
- Absolute Neutrophil Count Calculator
- Body Surface Area (BSA) Multi-Calc
- Carboplatin AUC Calculator
- Carboplatin AUC – Updated Version
- Urinary Indices, Renal Failure Index (RFI) and Fractional Excretion of Sodium (FE-NA)
- Creatinine Clearance (CRCL) – Standard Calculator
- Creatinine Clearance Multi-Calc – All of the latest research
- Patient Controlled Analgesia (PCA) Settings
- Intravenous Antineoplastic Agents – Administration Guidelines
- Therapeutic Drug Levels
- Beers Criteria for potentially inappropriate medications
- Allergic response? 12-step desensitization protocol
- Protein requirements calculator
- Basal Metabolic Rate (BMR) Multi-calc (Estimate caloric requirements)
- Irritable Bowel Syndrome Treatment Options
- Common Anti-emetics
- Fall Assessment – Berg Balance Scale
- Topical Steroids Potency Selection Tool
- Secukinumab Therapy In Psoriasis
- Lung Cancer Patients And Pulmonary Embolism Risk Factors
- Squamous Cell Carcinoma And Immunosuppression Risks
- Necrotizing Fasciitis Treatment And Bacterial Isolates Mortality Risk
- Acellular Dermal Matrix (ADM) For Burn And Trauma Wounds
- Visceral Adiposity And Heart Failure Risk
- Psoriasis Risk In Children With High BMI
- Traumatic Scalp Defects: Case Studies And Treatment Approaches
- Perforator Flaps For Patellar Defects
- GERD And Risk Factors Of Age And Obesity
- Cataract Repair: 20-Year Outcomes In Diabetic Patients
- Spitz Lesions: Clinical Outcomes
- Obesity Treatment With Tirzepatide And Semaglutide
- Hydroxyurea: Pediatric Use In Sickle Cell Anemia
- AKI In Alcohol-Related Hepatitis
- Biologic Therapy Tapering In Inflammatory Arthritis
- Rheumatoid Arthritis: Monitoring Disease With Neutrophil-To-Monocyte Ratio
- Cefuroxime Prophylaxis For Cataract Postoperative Endophthalmitis
- HIV Treatment And Long-Acting Therapy Preferences
- Idiopathic Parkinson’s Tremors: Treatment Options
- Ganaxolone Treatment For Refractory Epilepsy
- Bipolar Disorder And The Impact Of Insulin Sensitivity
- Blue Light Therapy For Melasma Patients
- Insulin Sensitivity In The Brain And Periphery
- Cabozantinib Therapy In Hepatocellular Carcinoma
- Obese Children And Related Skin Conditions
- PD-1/L1 Inhibitors: Treatment Efficacy In Urothelial Carcinoma
- Skin Lightening: Topical Approaches To Treatment
- PPE And Skin Related Reactions
- Encapsulated Papillary Carcinoma Membrane Characteristics
- Ibrutinib Treatment In Waldenström Macroglobulinemia
- Eyelid Carcinoma (SGC): A Tool To Predict Recurrence
- Stomach Cancer: A Meta-Analysis Of Robotic Surgery Complications
- Cognitive Behavioral Therapy In Patients With Insomnia And Chronic Fatigue
- Chemotherapy-Induced Thrombocytopenia In Nasopharyngeal Carcinoma
- Endocrine Therapy Outcomes In Senior Breast Cancer Patients
- Hepatocellular Treatment Outcomes: The Influence Of Butyrate Producers
- Non-Invasive Breast Carcinoma Treatment Outcomes
- Control Of Allergic Rhinitis And Asthma Test: A COSMIN Analysis
- Pilonidal Sinus Disease And Carcinoma Prevalence
- Sintilimab And Docetaxel Treatment Comparison In Advanced Lung Cancer
- Tislelizumab Treatment And Quality Of Life In Lung Cancer Patients
- Ciclopirox Hydrolacquer Therapy For Adult Onychomycosis
- Allergic Rhinitis And Genetic Risk Factors
- Serum Potassium Levels And Mortality Risk In CKD
- Postoperative Delirium In The NICU: Hormonal Risk Factors
- Onychomycosis And Diabetic Foot Syndrome
- Childhood BMI And Allergies: A Comprehensive Review
- Pediatric Onychomycosis Prevalence: A Systemic Review
- Hormone Disturbances In Migraine Disorder: A Meta-Analysis
- IGF-1 Levels In Pediatric Low-Level Gliomas
- Visual Field Defects In Patients With Pituitary Tumors
- Chronic Spontaneous Urticaria: Studying Age-Specific Therapies
- Levothyroxine Treatment In Patients With Thyroid Cancer
- Ocular Surgery In Infants And Post-Op Eye Drop Risks
- Cancer Care: Gender Bias In Decision-Making
- Respiratory Syncytial Virus Infection: A Tool For Assessing Clinical Severity
- Gynecologic Cancer Survivors: A Study Of Lifestyle Factors
- Non-Hodgkin Lymphoma Survivors: Secondary Malignancy Risk
- Antithyroid Drug Therapy And Cardiovascular Morbidity
- Eosinophilic Dermatosis In Hematological Malignancy (EDHM): Case Study Reports
- Uterine Leiomyosarcoma: A-Meta Analysis Of Systemic Therapy Effectiveness
- Off-Label Medication Use In Oncology
- Monocytosis And Patient Risk Of Malignancy And Mortality
- Bedside Pediatric Early Warning System: A Validation Study
- Chronic Hyponatremia In Heart Failure
- Massage Therapy For Oncology Patient Pain
- Eyelid Rhabdomyosarcoma Survival In Children’s Oncology
- Injured Athletes: A Meta-Analysis Comparing Topical And Oral Analgesic Efficacy
- Acute Myeloid Leukemia And Diverse Patient Survival Outcomes
- Sarcopenia And Chronic Kidney Disease
- Childhood Obesity: Targeted Dietary Interventions
- Supragastric Belching And Acid Reflux Severity
- Diabetic Peripheral Neuropathy Diagnosis Using Nerve Ultrasonography
- IBD: A Link To Cancer And Infection
- Renal Transplant Risks With Prostate Cancer
- COPD Risk With Diabetes And Pre-Diabetes
- Urothelial Carcinoma – Uretal And Renal Pelvic Tumors
- Merkel Cell Carcinoma: A Case Of Metastasis To The Tonsils
- Infant Formula Protein Content And Childhood Obesity
- Maternal Migraines And Associated Pediatric Cancers
- Pediatric Neuroblastoma Diagnosis Using Urinary Catecholamine Metabolites
- Finerenone Therapy In CKD And Type 2 Diabetes
- Binge Eating Habits And Diabetic Implications
- Pain Intensity In Idiopathic Inflammatory Myopathies And Rheumatic Diseases
- Melanoma Diagnosis Without Biopsy
- Pediatric Opioids And Pain Control In Fractures
- Daikenchuto Treatment For Chronic Constipation
- Prenatal Gingivitis Prevalence In A Clinical Trial Exploring Oral Hygiene Education
- Autistic Adults: A Study On Cognitive Therapy Experiences
- The Impact Of Long-Term Opioid Treatment On Endocrine Parameters
- Skeletal Muscle Index And Ovarian Cancer Prognosis: A Meta-Analysis
- Diabetes Mellitus During The Pandemic
- Carfilzomib Therapy In Pediatric Acute Lymphoblastic Leukemia
- Golimumab Compliance In Long-Term Arthritis Treatment
- Medullary Thyroid Cancer And Vocal Cord Paralysis
- Primary Adenocarcinoma Of The Orbit: A Case Study
- Survival Trends: Pancreatic Cancer in the USA
- Nusinersen Therapy For Pediatric Spinal Muscular Atrophy
- Pediatric Liver Transplantation: A New Biological Abdominal Wall
- Influenza Surveillance: A Review Of Data Sources
- Remission of Renal Cell Carcinoma With Brain Metastases: A Case Study
- Dry Eye Disease And Dehydration
- Macular Edema Therapy Using Dexamethasone Nanoparticle Suspension
- Colorectal Cancer Screening For Older Adults
- Satiation And Satiety: An Overview And Clinical Calculator
- Cholesterol Screening To Aid In Glaucoma Detection
- Hearing Screening After Chemotherapy: A Study On Childhood Cancer Survivors
- Olfactory Dysfunction and Screening For Depression: A QOL Study
- Cancer Diagnosis And Mental Health
- Mental Health Screening In Psoriatic Arthritis Patients
- Prostate Cancer: A New Biopsy Risk Calculator Using MRI
- Mental Health Study in Cancer Survivors
- Mental Health Screening In The Community
- Bone Mineral Density Screening Combined With Mammography
- Bone Mineral Density In Type 1 Diabetes Mellitus
- Cochlear Implants and Vestibular Screening
- Aprocitentan In Resistant Hypertension
- Predicting Cardiovascular Disease With Body Mass Index
- Obesity Screening To Predict Hot Flashes
- Hypertension Screening For Cardiovascular Health
- Dental Screening For Cardiovascular Disease Risk
- Blood Pressure and CVD Risk Reduction
- Lifestyle Changes For Hypoglycemia Prevention
- Ovarian Adenocarcinoma With Glaucoma: A Case Report
- Community Hypertension and Atherosclerosis Risk
- Thyroid Malignancy and Serum Calcitonin
- Rare Schwannoma In Lateral Nasal Wall
- Pyrotinib Therapy In HER2+ Breast Cancer
- Osteopenia Predicts Outcomes in Pancreatic Cancer
- Outcomes of Physical Exercise Regimens in Advanced Cancer
- Penile Squamous Cell Carcinoma And HPV
- Radiation Therapy And VTE Risk
- Pseudouveitis With Pancreatic Carcinoma: A Case Study
- Cancer Prevention In Rural Communities
- Skeletal Muscle Mass and Cancer Patient Quality of Life: A Meta-Analysis
- Incidence of Secondary Cancers After CIRT VS RT
- Filanesib Combination Therapy in Multiple Myeloma
- Pediatric Leukemia Patients Utilizing Levofloxacin
- Breast Cancer And An Analysis Of Cardiovascular Events
- Monotherapy Or Chemotherapy Adjunct: Pembrolizumab in Advanced NSCLC
- Advanced Gastric Cancer: Prognosis with Nivolumab Monotherapy
- Sinonasal B‐Cell Lymphomas A Cohort Study On Progression And Recurrence
- Platinum Resistant Recurrent Ovarian Cancer Treatment+/-Bevacizumab
- Metastatic Melanoma and Follow-Up MRI Scans
- Isatuximab Treatment in Refractory T-Acute Lymphoblastic Leukemia
- Ocular Melanoma and Treatment with Metformin
- Gastric Neuroendocrine Neoplasms
- Lung Cancer with Brain Metastasis After Late-Onset Bipolar Disorder: Case Report
- Anlotinib with Camrelizumab in Lung Cancer Treatment
- Sebaceous Carcinoma Treatment Outcomes: A Multicenter Study
- Diffuse-Type Tenosynovial Giant Cell Tumors: Treatment and Progression
- Lung Spindle Cell Carcinoma Responsive to Pembrolizumab: A Rare Case Report
- DNA Methylation Profiling in Sarcoma Classification
- Breast Tomosynthesis Simulator For Virtual Clinical Trials
- Renal Cell Carcinoma-Prognosis Via Albumin Levels
- Diagnostic Error Causing Cases of Cytopenia
- Hodgkin’s Lymphoma: A Case Study With Nystagmus and Diplopia
- Brugada Syndrome Treated with Lenalidomide: A Case Study
- Koolen-de Vries Case Study
- Suicidal Ideation and Somatic Treatments
- Study on Pavlovian Fear Conditioning and Fear Reversal in OCD
- Anxiety Scales in Lewy Body Disease
- Inoperable Locally Advanced Non-Small Cell Lung Cancer: Survival Rates of Endostar, CCRT
- Physician Practice Management and Private Equity
- Physician Spending And Its Association With Patient Outcomes
- Physician Burnout: Causes and Prevention
- LEAP-MS: Adaptations for Advanced Stages
- MS: Exercise Impacts on MRI
- The Role of Preretirement Job Complexity in Cognitive Performance
- Extrapontine Myelinolysis and PTA in Pregnancy
- Verbal Communication and Masks
- Sugammadex Versus Neostigmine in Thyroidectomy
- SGLT Inhibitors on Weight and Lipid Metabolism in Diabetes
- Saxagliptin: Obese Patients with Impaired Glucose Tolerance
- Levothyroxine Therapy and Depression
- Grave’s Disease and Risk of Systemic Lupus Erythematosus
- Benign Thyroid Removal and Patient Satisfaction
- MF- Biology, Management, and a Case Study of Ocular Manifestation
- Quality Of Life In Adolescent Cancer Survivors
- Cancer Opioid Risk Score
- Oncology-Specific Opioid Risk Calculator In Cancer Survivors
- 3D MRI for Non-invasive Ocular Proton Therapy of Uveal Melanomas
- Sexual Dysfunction in Prostate Cancer Patients
- 3-Day Surprise Question To Predict Survival Rates in Advanced Cancer Patients